Therefore, we sequenced WGA-DNA of two colon cancer samples (C1 and C2), known to harbor BRAF fusions (AGAP3-BRAF and TRIM24-BRAF, respectively)21, a sarcoma sample with a SS18-SSX1 fusion (S1) and a PDX sarcoma sample with unknown fusion status (S2). This evidence concerns the gene AGAP3 and colonic neoplasm.